ArticleJournal of geriatric oncology2024
Receipt of financial assistance for oral targeted therapy among older adults with advanced non-small cell lung cancer: A prospective cohort study.
Anika Kumar, Meera Ragavan, Ana I Velazquez, Sandra Zeng, Melisa L Wong
Abstract readLetter
In one paragraphArticle in Journal of geriatric oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Anika KumarSchool of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Meera RagavanDivision of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Ana I VelazquezDivision of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Sandra ZengDivision of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Melisa L WongDivision of Geriatrics, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Division of Research, Kaiser Permanente Northern California, The Permanente Medical Group, Oakland, CA, USA. Electronic address: melisa.wong@kp.org.
Funding
VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Louise C. Walter · 2013 to 2026
$19.9MInstitutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7MRESOURCE CENTER FOR AGING RESEARCH IN DIVERSE POPULATIONP30AG015272 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Torsten Brian Neilands · 1997 to 2026
$19.5MImplementation and evaluation of multiple recruitment research strategies for persons living with HIV in the CAMPO clinical trials in the Puerto Rico siteU54CA242646 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ, ANA PATRICIA, PALEFSKY, JOEL MICHAEL · 2019 to 2025
$10.2MAdvancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussionsK76AG064431 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WONG, MELISA L · 2019 to 2023
$1.3MExpanding the Definition of Treatment Toxicity in Older Adults with Lung CancerR03AG056439 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WONG, MELISA L · 2017 to 2018
$238kNCATS NIH HHS KL2 TR001870NCI NIH HHS U54 CA242646NIA NIH HHS K76 AG064431NIA NIH HHS P30 AG015272NIA NIH HHS P30 AG044281NIA NIH HHS R03 AG056439
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Non-Small-Cell LungLung NeoplasmsAdministration, OralAgedAged, 80 and overAntineoplastic AgentsFemaleHumansMaleMedical AssistanceMolecular Targeted TherapyProspective StudiesAntineoplastic AgentsFinancial assistanceFinancial toxicityLung cancerOlder adults
Identifiers
PMID38490915
PMCPMC11153012
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390